Neural Plasticity and Proliferation in the Generation of Antidepressant Effects: Hippocampal Implication
Authors:
Open Access
- 1 January 2013
- journal article
- review article
- Published by Wiley in Neural Plasticity
- Vol. 2013 (1) , 537265
Abstract
It is widely accepted that changes underlying depression and antidepressant‐like effects involve not only alterations in the levels of neurotransmitters as monoamines and their receptors in the brain, but also structural and functional changes far beyond. During the last two decades, emerging theories are providing new explanations about the neurobiology of depression and the mechanism of action of antidepressant strategies based on cellular changes at the CNS level. The neurotrophic/plasticity hypothesis of depression, proposed more than a decade ago, is now supported by multiple basic and clinical studies focused on the role of intracellular‐signalling cascades that govern neural proliferation and plasticity. Herein, we review the state‐of‐the‐art of the changes in these signalling pathways which appear to underlie both depressive disorders and antidepressant actions. We will especially focus on the hippocampal cellularity and plasticity modulation by serotonin, trophic factors as brain‐derived neurotrophic factor (BDNF), and vascular endothelial growth factor (VEGF) through intracellular signalling pathways—cAMP, Wnt/ β ‐catenin, and mTOR. Connecting the classic monoaminergic hypothesis with proliferation/neuroplasticity‐related evidence is an appealing and comprehensive attempt for improving our knowledge about the neurobiological events leading to depression and associated to antidepressant therapies.Keywords
Funding Information
- Ministry of Science (SAF04-00941)
- Ministry of Science (SAF07-61862)
- Ministry of Science (SAF04-00941)
- Ministry of Science (SAF07-61862)
- Fundación Alicia Koplowitz (SAF04-00941)
- Fundación Alicia Koplowitz (SAF07-61862)
- Fundación de Investigación Médica Mutua Madrileña (SAF04-00941)
- Fundación de Investigación Médica Mutua Madrileña (SAF07-61862)
- Instituto de Salud Carlos III (SAF04-00941)
- Instituto de Salud Carlos III (SAF07-61862)
- University of Cantabria-FAES research contract (SAF04-00941)
- University of Cantabria-FAES research contract (SAF07-61862)
This publication has 264 references indexed in Scilit:
- α2-Adrenoceptor Functionality in Postmortem Frontal Cortex of Depressed Suicide VictimsBiological Psychiatry, 2010
- Blocked Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3α/β Impairs In Vivo Neural Precursor Cell ProliferationBiological Psychiatry, 2009
- The 5-HT7 receptor is involved in allocentric spatial memory information processingBehavioural Brain Research, 2009
- The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortexBehavioural Brain Research, 2009
- Endogenous Wnt Signaling Maintains Neural Progenitor Cell PotencyStem Cells, 2009
- Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and ImplicationsBiological Psychiatry, 2008
- Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant ReversalBiological Psychiatry, 2008
- Generation and behavioral characterization of β-catenin forebrain-specific conditional knock-out miceBehavioural Brain Research, 2008
- Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant EfficacyBiological Psychiatry, 2008
- Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progressionCell, 1993